130 related articles for article (PubMed ID: 16280698)
1. Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.
Pence BW; Gaynes BN; Whetten K; Eron JJ; Ryder RW; Miller WC
J Acquir Immune Defic Syndr; 2005 Dec; 40(4):434-44. PubMed ID: 16280698
[TBL] [Abstract][Full Text] [Related]
2. A brief mental health and substance abuse screener for persons with HIV.
Whetten K; Reif S; Swartz M; Stevens R; Ostermann J; Hanisch L; Eron JJ
AIDS Patient Care STDS; 2005 Feb; 19(2):89-99. PubMed ID: 15716640
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
Pence BW; Miller WC; Gaynes BN; Eron JJ
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):159-66. PubMed ID: 17146374
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States.
Pence BW; Miller WC; Whetten K; Eron JJ; Gaynes BN
J Acquir Immune Defic Syndr; 2006 Jul; 42(3):298-306. PubMed ID: 16639343
[TBL] [Abstract][Full Text] [Related]
5. The validity of the Substance Abuse and Mental Illness Symptom Screener (SAMISS) in people living with HIV/AIDS in primary HIV care in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska JA
AIDS Behav; 2014 Jun; 18(6):1133-41. PubMed ID: 24452497
[TBL] [Abstract][Full Text] [Related]
6. Association Between Substance Abuse and Mental Illness Symptoms Screener (SAMISS) Scores and HIV Care Continuum Outcomes in People Newly Diagnosed with HIV in the US South.
Ahmed M; Nijhawan AE; Gao A; Ahn C; Chow JY
AIDS Behav; 2024 May; 28(5):1731-1740. PubMed ID: 38361170
[TBL] [Abstract][Full Text] [Related]
7. Reliability of the lay adherence counsellor administered substance abuse and mental illness symptoms screener (SAMISS) and the International HIV Dementia Scale (IHDS) in a primary care HIV clinic in Cape Town, South Africa.
Breuer E; Stoloff K; Myer L; Seedat S; Stein DJ; Joska J
AIDS Behav; 2012 Aug; 16(6):1464-71. PubMed ID: 22001934
[TBL] [Abstract][Full Text] [Related]
8. Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Ettner SL;
J Acquir Immune Defic Syndr; 2008 Apr; 47(4):449-58. PubMed ID: 18197121
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Client Diagnostic Questionnaire to Assess Mental Health in South African Caregivers of Children.
Mellins CA; Kauchali S; Nestadt DF; Bai D; Aidala A; Myeza N; Craib MH; Kvalsvig J; Leu CS; Knox J; Arpadi S; Chhagan M; Davidson LL
Clin Psychol Psychother; 2017 Jan; 24(1):245-254. PubMed ID: 26923182
[TBL] [Abstract][Full Text] [Related]
10. Are clinical impressions of adolescent substance use accurate?
Wilson CR; Sherritt L; Gates E; Knight JR
Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
[TBL] [Abstract][Full Text] [Related]
11. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.
Knight JR; Sherritt L; Shrier LA; Harris SK; Chang G
Arch Pediatr Adolesc Med; 2002 Jun; 156(6):607-14. PubMed ID: 12038895
[TBL] [Abstract][Full Text] [Related]
12. The impact of mental health and substance abuse factors on HIV prevention and treatment.
Walkup J; Blank MB; Gonzalez JS; Safren S; Schwartz R; Brown L; Wilson I; Knowlton A; Lombard F; Grossman C; Lyda K; Schumacher JE
J Acquir Immune Defic Syndr; 2008 Mar; 47 Suppl 1():S15-9. PubMed ID: 18301129
[TBL] [Abstract][Full Text] [Related]
13. Validity and reliability of the COJAC screening tool for co-occurring disorders.
Jessup MA; Dibble SL
Am J Addict; 2011; 20(3):264-70. PubMed ID: 21477055
[TBL] [Abstract][Full Text] [Related]
14. Screening of mental health and substance users in frequent users of a general Swiss emergency department.
Vu F; Daeppen JB; Hugli O; Iglesias K; Stucki S; Paroz S; Canepa Allen M; Bodenmann P
BMC Emerg Med; 2015 Oct; 15():27. PubMed ID: 26452550
[TBL] [Abstract][Full Text] [Related]
15. Validation of a brief mental health screening tool for common mental disorders in primary healthcare.
Bhana A; Mntambo N; Gigaba SG; Luvuno ZPB; Grant M; Ackerman D; Ntswe E; Nomathemba M; Petersen I
S Afr Med J; 2019 Mar; 109(4):278-283. PubMed ID: 31084695
[TBL] [Abstract][Full Text] [Related]
16. Development and internal validation of a risk prediction model for HIV disease severity among people living with HIV and mental illness or substance use disorder.
Iloanusi S; Yunusa I; Mgbere O; Abughosh SM; Chen H; Essien EJ
Ann Epidemiol; 2023 Nov; 87():79-92. PubMed ID: 37742879
[TBL] [Abstract][Full Text] [Related]
17. Assessing an Epidemic: Utility of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Level 2 Substance Use Screener in Adult Psychiatric Inpatients.
Sullivan MC; Strainge L; Blackmon JE; Cruess SE; Wheeler D; Cruess DG
J Addict Nurs; 2020; 31(1):9-16. PubMed ID: 32132419
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse and symptoms of mental illness among HIV-positive persons in the Southeast.
Whetten K; Reif SS; Napravnik S; Swartz MS; Thielman NM; Eron JJ; Lowe K; Soto T
South Med J; 2005 Jan; 98(1):9-14. PubMed ID: 15678633
[TBL] [Abstract][Full Text] [Related]
19. Dual diagnosis vs. triple diagnosis in HIV: a comparative study to evaluate the differences in psychopathology and suicidal risk in HIV positive male subjects.
Gupta M; Kumar K; Garg PD
Asian J Psychiatr; 2013 Dec; 6(6):515-20. PubMed ID: 24309864
[TBL] [Abstract][Full Text] [Related]
20. Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument.
Mestre-Pintó JI; Domingo-Salvany A; Martín-Santos R; Torrens M;
Eur Addict Res; 2014; 20(1):41-8. PubMed ID: 23921461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
